HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nasser S Al-Shakliah Selected Research

tandutinib

1/2021Identification and characterization of in vitro, in vivo, and reactive metabolites of tandutinib using liquid chromatography ion trap mass spectrometry.
1/2020LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nasser S Al-Shakliah Research Topics

Disease

4Neoplasms (Cancer)
08/2021 - 01/2020
2Breast Neoplasms (Breast Cancer)
08/2021 - 01/2020
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2020
1Cholangiocarcinoma
08/2021
1Atrial Fibrillation
05/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
05/2021
1Hemorrhage
05/2021
1Pulmonary Embolism
05/2021
1Peripheral Arterial Disease
05/2021
1Thrombosis (Thrombus)
05/2021
1Melanoma (Melanoma, Malignant)
05/2021
1Drug-Related Side Effects and Adverse Reactions
05/2021
1Phototoxic Dermatitis (Phototoxicity)
09/2018
1Floating-harbor syndrome
06/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2016

Drug/Important Bio-Agent (IBA)

5Phosphotransferases (Kinase)IBA
08/2021 - 01/2020
4Pharmaceutical PreparationsIBA
08/2021 - 01/2020
4tyrosine receptor (receptor, tyrosine)IBA
08/2021 - 01/2020
3Tyrosine Kinase InhibitorsIBA
08/2021 - 08/2016
2infigratinibIBA
08/2021 - 04/2020
2tandutinibIBA
01/2021 - 01/2020
1MicellesIBA
08/2021
1GSK 1363089IBA
08/2021
1TabletsIBA
08/2021
1RivaroxabanIBA
05/2021
1AnticoagulantsIBA
05/2021
1encorafenibIBA
05/2021
1binimetinibIBA
05/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
04/2020
1Surface-Active Agents (Surfactants)IBA
01/2020
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
01/2020
1Lapatinib (GW572016)FDA Link
01/2020
1vandetanib (ZD6474)IBA
09/2018
1HydrazonesIBA
06/2017
1Fluorescein (Funduscein)FDA LinkGeneric
06/2017
1Topoisomerase InhibitorsIBA
06/2017
1AfatinibIBA
08/2016

Therapy/Procedure

2Therapeutics
05/2021 - 01/2020